Welcome to the “World Lending Library”

	Name	Size
	Parent Directory	-
	Smith.Psychedelic Chemistry 2e HTML/	-
	1959.Hofmann.Abwandlungsprodukte von Psilocybin und Psilocin.pdf	1.5M
	1959.Hofmann.Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzenl.pdf	1.1M
	1959.Isbell.Comparison of the Reactions Induced by Psilocybin.pdf	598K
	1998.Gouzoulis.Psychopathological effects of MDE, psilocybin and meth.pdf	280K
	1999.Neurometabolic Effects of Psilocybin.pdf	943K
	2001.Horgan.The future of mind science.pdf	85K
	2001.Nichols.LSD and Its Lysergamide Cousins.pdf	263K
	2001.Nichols.Serotonin Receptor Signaling and Hallucinogenic Drug Action.pdf	469K
	2001.Perrine.Visions of the Night.Western Medicine Meets Peyote 1887-1899.pdf	562K
	2002.Passie et al. Pharmacology of psilocybin.pdf	180K
	2003.Hasler.Acute psychological and physiological effects of psilocybin.pdf	316K
	2006.Griffiths.Psilocybin can occasion mystical-type experiences.pdf	334K
	2006.Kleber.Commentary on Psilocybin can occasion mystical-type experiences .pdf	65K
	2006.Moreno et al. Psilocybin and OCD.pdf	106K
	2006.Nichols.Commentary on Psilocybin can occasion mystical-type experiences .pdf	76K
	2006.Schuster.Commentary on Psilocybin can occasion mystical-type experiences .pdf	55K
	2006.Snyder.Commentary on Psilocybin can occasion mystical-type experiences.pdf	58K
	2007.Jerome.Psilocybin - Investigator's Brochure.pdf	145K
	2011.Amsterdam et al. Harm potential of magic mushroom use 2011.pdf	213K
	2011.Carhart-Harris.psychedelic state as determined by fMRI studies with psilocybin.pdf	1.2M
	2011.Griffiths.Psilocybin occasioned mystical-type experiences immediate and persisting dose-related effects.pdf	409K
	2011.MacLean.Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.pdf	172K
	2012.Carhart-Harris.Implications for psychedelic-assisted psychotherapy MRI with psilocybin.pdf	601K
	2014.Kraehenmann.Psilocybin-Induced Decrease in Amygdala Reactivity.pdf	756K